Reza Arefnezhad

Mr. Reza Arefnezhad


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Pathology - Research and Practice
Verified
Journal Article
Closed access
FGFaezeh Ghasemi
Faezeh Ghasemi
MSMojtaba Shafiee
Mojtaba Shafiee
ZBZarrin Banikazemi
Zarrin Banikazemi
MPMohammad Hossein Pourhanifeh
Mohammad Hossein Pourhanifeh
HKHashem Khanbabaei
Hashem Khanbabaei
HMHamed Mirzaei
Hamed Mirzaei

1 September 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SSSahand Sadeghi
Sahand Sadeghi
ADAmirhossein Davoodvandi
Amirhossein Davoodvandi
MPMohammad Hossein Pourhanifeh
Mohammad Hossein Pourhanifeh
NSNasrin Sharifi
Nasrin Sharifi
RAReza Arefnezhad
Reza Arefnezhad
HMHamed Mirzaei
Hamed Mirzaei

6 July 2022 in Pharmacology
Verified
Journal Article
Closed access
PDF file
FSFaezeh Samadi
Faezeh Samadi
MKMohammad Saeed Kahrizi
Mohammad Saeed Kahrizi
FHFateme Heydari
Fateme Heydari
RAReza Arefnezhad
Reza Arefnezhad
HRHossein Roghani-Shahraki
Hossein Roghani-Shahraki
FRFatemeh Rezaei-Tazangi
Fatemeh Rezaei-Tazangi
Background: Osteoarthritis (OA), as one of the chronic debilitating conditions, affects 15% of people globally and is linked with serious problems, such as cardiovascular diseases, metabolic syndrome, and autoimmune inflammatory disorders. The current therapeutic options for this disease include nonsteroidal anti-inflammatory drugs, surgery, gene therapy, intrasynovial gel injection, and warm needle penetration. However, these approaches may be accompanied by considerable side effects, high costs, and some limitations for patients. Thus, using an alternative way is needed. Summary: Presently, natural compounds based-therapies, like flavonoids, have acquired much attention in the current era. One of the compounds belonging to the flavonoid family is quercetin, and its therapeutic effects on disorders related to joints and cartilage have been addressed in vivo and in vitro studies. Key Messages: In this review, we summarized evidence indicating its curative capacity against OA with a mechanistic insight.

17 December 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
FRFatemeh Rezaei-Tazangi
Fatemeh Rezaei-Tazangi
HRHossein Roghani-Shahraki
Hossein Roghani-Shahraki
MGMahdi Khorsand Ghaffari
Mahdi Khorsand Ghaffari
FZFiroozeh Abolhasani Zadeh
Firoozeh Abolhasani Zadeh
ABAynaz Boostan
Aynaz Boostan
HMHossein Motedayyen
Hossein Motedayyen
Ovarian cancer (OCa) is characterized as one of the common reasons for cancer-associated death in women globally. This gynecological disorder is chiefly named the “silent killer” due to lacking an association between disease manifestations in the early stages and OCa. Because of the disease recurrence and resistance to common therapies, discovering an effective therapeutic way against the disease is a challenge. According to documents, some popular herbal formulations, such as curcumin, quercetin, and resveratrol, can serve as an anti-cancer agent through different mechanisms. However, these herbal products may be accompanied by some pharmacological limitations, such as poor bioavailability, instability, and weak water solubility. On the contrary, using nano-based material, e.g., nanoparticles (NPs), micelles, liposomes, can significantly solve these limitations. Therefore, in the present study, we will summarize the anti-cancer aspects of these herbal and-nano-based herbal formulations with a focus on their mechanisms against OCa.

20 January 2021 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
HRHossein Roghani-Shahraki
Hossein Roghani-Shahraki
MKMohammad Karimian
Mohammad Karimian
SVSaboora Valipour
Saboora Valipour
MBMohaddeseh Behjati
Mohaddeseh Behjati
RAReza Arefnezhad
Reza Arefnezhad
AMAbolfazl Mousavi
Abolfazl Mousavi

1 November 2020 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
RKReza Daneshvar Kakhki
Reza Daneshvar Kakhki
MDMaryam Dehghanei
Maryam Dehghanei
RAReza Arefnezhad
Reza Arefnezhad
HMHossein Motedayyen
Hossein Motedayyen